Intention to Re-Domicile (5535E)
01 June 2012 - 4:00PM
UK Regulatory
TIDMPHRM
RNS Number : 5535E
Phorm Inc
01 June 2012
1 June 2012
Phorm, Inc. ('Phorm' or 'the Company')
Intention to Re-Domicile
Phorm (AIM: PHRM and PHRX), the internet personalisation
technology company, announces its intention to re-domicile the
holding company of the group from Delaware to Singapore. This will
simplify the settlement mechanics relating to the trading in the
Company's shares under the symbol PHRM by removing the requirement
for certificated settlement of shares and allowing them to be
traded electronically in CREST. The Directors believe this will
provide significant assistance to the shares' liquidity. Further
information relating to the proposed re-domicile will be provided
at the Company's up coming AGM on 19 June 2012.
For Enquiries
Phorm, Inc.
Mark Williams (analysts & investors) +44 20 7297 2326
Alex Laity (media) +44 20 7297 2710
Liberum Capital +44 20 3100 2222
(Nominated Advisor and Joint Broker)
Chris Bowman
Richard Bootle
Mirabaud Securities LLP +44 20 7321 2508
(Joint Broker)
Jason Woollard
Peter Krens
- ends -
About Phorm
Phorm is a global personalisation technology company that makes
content and advertising more relevant to the consumer. Phorm's
innovative platform preserves user privacy and delivers a more
interesting online experience.
Phorm's partners include leading Internet Service Providers
(ISPs), Publishers, Ad Networks and Advertisers.
A Delaware, US incorporated company, Phorm was admitted to the
AIM market of the London Stock Exchange in 2004 and has over 140
employees and contractors.
For more information, please visit: www.phorm.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSDDFLFFESEII
Phorm Corp (LSE:PHRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Phorm Corp (LSE:PHRM)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Phorm Corp (London Stock Exchange): 0 recent articles
More Phorm Reg S News Articles